Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Repurposed Hepatitis C Drugs for COVID-19 Treatment Could Break Life Cycle of Coronavirus

By HospiMedica International staff writers
Posted on 11 Sep 2020
A team of researchers have identified antiviral drugs used to treat hepatitis C that are protease inhibitors and could be repurposed for use as treatment for COVID-19.

Researchers from the University of Washington (UW) Medicine (Seattle, Wash., USA) examined 6,800 known drugs with a history of safe use in humans that could possibly break the life cycle of the coronavirus by blocking an important protein called the main protease. More...
The team singled out boceprevir and narlaprevir, protease inhibitors developed by Merck & Co. that have been superceded by more effective hepatitis C treatments.

The researchers believe that if these drugs prove effective against the novel coronavirus in clinical trials, they can be used as part of a combination therapy to adopt more than one line of attack against the virus. According to the researchers, finding potent treatments among approved drugs offers an advantage as they “can be advanced rapidly to clinical trials without extensive multi-year preclinical development efforts.”

Related Links:
University of Washington


Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Multi-Chamber Washer-Disinfector
WD 390
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.